myeloid leukemia in chronic phase treated with frontline nilotinib or Early molecular response predicts outcomes in patients with chronic
暂无分享,去创建一个
R. Larson | H. Kantarjian | R. Ribeiro | G. Rosti | D. Niederwieser | G. Saglio | M. Kalaycio | C. Nakaseko | A. Hochhaus | F. Guilhot | T. Hughes | H. Menssen | C. Souza | Xiaolin Fan | S. Meier | T. Hughes